Literature DB >> 1341716

Survival in metastatic breast cancer after combination of radio-chemotherapy and hyperthermia.

P Pontiggia.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1341716

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


× No keyword cloud information.
  4 in total

1.  Short-term chemotherapy of poor-prognosis metastatic breast cancer with three non-cross resistant chemotherapy regimens. A Southwest Oncology Group Study.

Authors:  F R Ahmann; R Pugh
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

2.  A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.

Authors:  R V Smalley; J Lefante; A Bartolucci; J Carpenter; C Vogel; S Krauss
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association.

Authors:  H B Muss; L D Case; F Richards; D R White; M R Cooper; J M Cruz; B L Powell; C L Spurr; R L Capizzi
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

4.  Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer.

Authors:  A L Harris; B M Cantwell; J Carmichael; R Wilson; J Farndon; P Dawes; S Ghani; R G Evans
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.